^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Soft Tissue Sarcoma
    Drug:doxorubicin hydrochloride (Topoisomerase II inhibitor) +
    ifosfamide (Bifunctional alkylating agent) +
    mesna (Antioxidant)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    04/28/2021
    Excerpt:
    Soft Tissue Sarcoma: Preferred Regimens...AIM (doxorubicin, ifosfamide, mesna)